
N-Benzyl-4-piperidone | CAS:3612-20-2
N-Benzyl-4-piperidone
- 名称:N-苄基-4-哌啶酮 | N-Benzyl-4-piperidone
- CAS号:3612-20-2
- 别名:1-(Phenylmethyl)-4-piperidinone; 1-Benzylpiperidin-4-one
- 分子式:C12H15NO
- 分子量:189.26
- EINESC号:222-782-4
产品描述
物理化学性质
水溶性 | 12 g/L (20 ºC) |
---|---|
沸点 | 114-116 ºC (0.4 mmHg) |
闪点 | 71 ºC |
密度 | 1.069 |
折射率 | 1.539-1.54 |
安全数据
危险品标志 | Xn |
---|---|
危险类别码 | R22;R43 |
安全说明书 | S26;S37/39 |
产品合成路线
文章
同行评议文献
Bradykinin is not involved in angiotensin converting enzyme modulation of ovarian steroidogenesis and prostaglandin production in frog Rana esculenta.M Bramucci et al.Acta physiologica Scandinavica, 175(2), 123-128 (2002-05-25)
Ixodes scapularis: salivary kininase activity is a metallo dipeptidyl carboxypeptidase.J M Ribeiro et al.Experimental parasitology, 89(2), 213-221 (1998-06-27)
Measurement of des-Phe8-Arg9-bradykinin by enzyme-immunoassay--a useful parameter of plasma kinin release.M Majima et al.Advances in experimental medicine and biology, 247B, 331-335 (1989-01-01)
Evidence for the involvement of a plasma kallikrein-kinin system in the immediate hypotension produced by endotoxin in anaesthetized rats.M Katori et al.British journal of pharmacology, 98(4), 1383-1391 (1989-12-01)
Blood levels of kinins in experimental allergic encephalomyelitis.L Germain et al.Journal of neuroimmunology, 13(2), 135-142 (1986-12-01)
A stable metabolite, Arg-Pro-Pro-Gly-Phe, of bradykinin in the degradation pathway in human plasma.C Shima et al.Japanese journal of pharmacology, 60(2), 111-119 (1992-10-01)
Purification and characterization of bioactive peptides from skin extracts of Rana esculenta.M Simmaco et al.Biochimica et biophysica acta, 1033(3), 318-323 (1990-03-26)
Increased blood concentration of des-Arg9-bradykinin in experimental allergic encephalomyelitis.L Germain et al.Journal of the neurological sciences, 83(2-3), 211-217 (1988-02-01)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!